Research Funded by Bay Area Lyme Foundation Identifies New Investigational Therapy Regimen Capable of Irreversibly Damaging Lyme Bacteria in Laboratory Tests
November 01, 2023 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the development of a potential new drug,...
Bay Area Lyme Foundation Now Accepting Applications for 2024 Emerging Leader Award and Grant
October 26, 2023 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, is announcing a call for entries for their 2024 Emerging...
Bay Area Lyme Foundation ELA Winner Uses Metabolic Modeling to Predict 77 Unique Drug Targets in Lyme Disease Bacterium
October 19, 2023 11:02 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the findings of a study identifying new...
Research funded by Bay Area Lyme Foundation provides most comprehensive and geographically widespread whole genome sequencing of Lyme bacteria
August 31, 2023 14:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the results of the most comprehensive whole...
Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research
August 14, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Lyme disease diagnostics market is expected to total US$ 1.56 billion in 2023...
Bay Area Lyme Foundation Celebrates Its 10th Anniversary with a Convergence of Scientists, Clinicians, Patients and Celebrity Talent
June 13, 2023 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, celebrated its 10th anniversary in May at LymeAid®, its...
Bay Area Lyme Foundation Celebrates Department of Defense CDMRP Tick-borne Disease Awardees
March 23, 2023 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces that two projects it has previously funded have...
National Lyme Clinical Trials Network Gains Its First West Coast Center, Thanks to $1M+ Donation from Bay Area Lyme Foundation
March 09, 2023 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, announces it has awarded more than $1M to the University of...
Bay Area Lyme Foundation Researcher Validates New Approach to Overcome Challenges of Lyme Disease Diagnosis in the Lab
February 06, 2023 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a laboratory study published in...
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease
December 15, 2022 08:30 ET
|
Tarsus Pharmaceuticals, Inc
Positive Phase 1b Callisto data shows that TP-05 is well tolerated and safety data supports progression to Phase 2a Phase 2a Carpo trial to evaluate the safety, tolerability, and proof-of-activity of...